بنما - الإنجليزية - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

stendhal panama, s.a - gemigliptina (tartrato sesquihidratado) - gemigliptina (tartrato sesquihidratado)....50.00 mg

بنما - الإنجليزية - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

stendhal panamÁ s.a. - fimasartan potÁsico (trihidratado) - fimasartan potÁsico (trihidratado)....60.00 mg

بنما - الإنجليزية - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

stendhal panamÁ s.a. - netupitant - netupitant....300 mg (3 tabletas de 100mg) / palonosetron (clorhidrato)....0.5 mg

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

aa-med pty ltd - 61288 - home seizure monitoring system - the embrace is a wearable device, worn on the wrist of a child or adult, for use in home or in professional healthcare environments. it senses electro dermal activity and motion data in order to detect patterns that may indicate a possible convulsive seizure in patients with epilepsy or at risk of having epilepsy. when a seizure event is detected, it sends a command to a paired wireless device that is programmed to initiate an alert (or send an alarm) to a designated caregiver. it is optimized to detect seizures involving electro dermal activity and motion patterns with a duration of at least 20 seconds.these characteristics are generally associated with tonic-clonic seizures. it doesn?t detect every single generalized tonic-clonic seizure. it is not meant as substitute to seizure monitoring practices, but rather to serve as a supplement in expediting first-response time. it cannot detect complex partial seizures, absence seizures and non-convulsive seizures.

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

mist pharmaceuticals, llc - avanafil (unii: dr5s136ivo) (avanafil - unii:dr5s136ivo) - avanafil 50 mg - stendra is a phosphodiesterase 5 (pde5) inhibitor indicated for the treatment of erectile dysfunction. administration of stendra with any form of organic nitrates, either regularly and/or intermittently, is contraindicated. consistent with its known effects on the nitric oxide/cyclic guanosine monophosphate (cgmp) pathway, stendra has been shown to potentiate the hypotensive effects of nitrates. in a patient who has taken stendra, where nitrate administration is deemed medically necessary in a life-threatening situation, at least 12 hours should elapse after the last dose of stendra before nitrate administration is considered. in such circumstances, nitrates should only be administered under close medical supervision with appropriate hemodynamic monitoring [see contraindications (4.1) , dosage and administration (2.3) , and clinical pharmacology (12.2) ] . stendra is contraindicated in patients with a known hypersensitivity to any component of the tablet. hypersensitivity reactions have been reported, incl

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

metuchen pharmaceuticals, llc - avanafil (unii: dr5s136ivo) (avanafil - unii:dr5s136ivo) - stendra is a phosphodiesterase 5 (pde5) inhibitor indicated for the treatment of erectile dysfunction in adult males. administration of stendra with any form of organic nitrates, either regularly and/or intermittently, is contraindicated. consistent with its known effects on the nitric oxide/cyclic guanosine monophosphate (cgmp) pathway, stendra has been shown to potentiate the hypotensive effects of nitrates. in a patient who has taken stendra, where nitrate administration is deemed medically necessary in a life-threatening situation, at least 12 hours should elapse after the last dose of stendra before nitrate administration is considered. in such circumstances, nitrates should only be administered under close medical supervision with appropriate hemodynamic monitoring [see contraindications (4.1) , dosage and administration (2.3) , and clinical pharmacology (12.2) ] . stendra is contraindicated in patients with a known hypersensitivity to any component of the tablet. hypersensitivity reactions have been

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

vivus llc - avanafil (unii: dr5s136ivo) (avanafil - unii:dr5s136ivo) - stendra is a phosphodiesterase 5 (pde5) inhibitor indicated for the treatment of erectile dysfunction. administration of stendra with any form of organic nitrates, either regularly and/or intermittently, is contraindicated. consistent with its known effects on the nitric oxide/cyclic guanosine monophosphate (cgmp) pathway, stendra has been shown to potentiate the hypotensive effects of nitrates. in a patient who has taken stendra, where nitrate administration is deemed medically necessary in a life-threatening situation, at least 12 hours should elapse after the last dose of stendra before nitrate administration is considered. in such circumstances, nitrates should only be administered under close medical supervision with appropriate hemodynamic monitoring [see contraindications (4.1), dosage and administration (2.3), and clinical pharmacology (12.2)] . stendra is contraindicated in patients with a known hypersensitivity to an

جنوب أفريقيا - الإنجليزية - South African Health Products Regulatory Authority (SAHPRA)

ruby pharmaceuticals (pty) ltd - tablet - 50,0 mg - each tablet contains sildenafil citrate equivalent to sildenafil 50,0 mg

جنوب أفريقيا - الإنجليزية - South African Health Products Regulatory Authority (SAHPRA)

ruby pharmaceuticals (pty) ltd - tablet - 100,0 mg - each tablet contains sildenafil citrate equivalent to sildenafil 100,0 mg

جنوب أفريقيا - الإنجليزية - South African Health Products Regulatory Authority (SAHPRA)

ruby pharmaceuticals (pty) ltd - tablet - 25,0 mg - each tablet contains sildenafil citrate equivalent to sildenafil 25,0 mg